BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2011
View Archived Issues
Irbesartan/amlodipine besilate combination lowers blood pressure uncontrolled by either agent alone
Read More
Terutroban not more protective than aspirin in PERFORM trial in patients with prior stroke
Read More
Candesartan is not beneficial as blood pressure-lowering therapy in SCAST trial
Read More
Phase II data on ENMD-2076 in ovarian cancer reported at ASCO meeting
Read More
Scientists at Lytix Biopharma generate novel antimicrobials
Read More
Azanin tablets are approved for additional indications in Japan
Read More
Opexa meets with Health Canada regarding planned trials of Tovaxin in MS
Read More
NI-1201 targets classic and trans IL-6 signaling pathways, showing promise to treat inflammation
Read More
CYT-387 improves anemia in phase I/II trial in myelofibrosis
Read More
New GCS activators designed by Auspex Pharmaceuticals
Read More
Bristol-Myers Squibb claims new nicotinic acetylcholine alpha7 receptor agonists
Read More
Takeda presents novel tachykinin NK2 receptor antagonists
Read More
Tibotec discloses new inhibitors of HCV replication
Read More
BioDelivery Sciences provides update on modified REMS program for Onsolis
Read More
ImmunoCellular Therapeutics to use BioWa's Potelligent technology for anticancer antibodies
Read More
ACE-011 enters phase II/III trial to treat chemotherapy-induced anemia in patients with NSCLC
Read More
Adeona reports results from analysis of phase I/II data on reaZin in Alzheimer's disease
Read More
Morphotek begins phase II MORAb-004 study in melanoma
Read More
Health Canada approves AstraZeneca Canada's Brilinta
Read More
Phase III Get-Goal-L trial of lixisenatide in type 2 diabetes meets primary endpoint
Read More
Algeta to stop phase III ALSYMPCA trial of Alpharadin based on statistically significant efficacy
Read More
Orexigen Therapeutics to appeal FDA's decision regarding Contrave NDA
Read More
FDA accepts for review Sunovion's NDA for Nycomed's ciclesonide HFA nasal aerosol
Read More
Novartis gains approval in Europe for new indication of Lucentis
Read More
Ligand grants worldwide license to Captisol-enabled clopidogrel to The Medicines Company
Read More